These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26673349)

  • 1. Recent advances in the field of anti-cancer immunotherapy.
    Neves H; Kwok HF
    BBA Clin; 2015 Jun; 3():280-8. PubMed ID: 26673349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Recent advances in discovering molecular targets for cancer therapy.
    Yang Z; Wang T
    Front Med (Lausanne); 2024; 11():1403466. PubMed ID: 38779619
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy advances: One year on.
    Elliott T
    Immunother Adv; 2022; 2(1):ltac001. PubMed ID: 35919492
    [No Abstract]   [Full Text] [Related]  

  • 4. Introducing
    Elliott T
    Immunother Adv; 2021 Jan; 1(1):ltaa009. PubMed ID: 36284897
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy and immunotherapy: mapping the road ahead.
    Cook AM; Lesterhuis WJ; Nowak AK; Lake RA
    Curr Opin Immunol; 2016 Apr; 39():23-9. PubMed ID: 26724433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy.
    Chester C; Fritsch K; Kohrt HE
    Front Immunol; 2015; 6():601. PubMed ID: 26697006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential.
    Wurz GT; Kao CJ; DeGregorio MW
    Ther Adv Med Oncol; 2016 Jan; 8(1):4-31. PubMed ID: 26753003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosurveillance and immunotherapy of tumors by innate immune cells.
    Iannello A; Thompson TW; Ardolino M; Marcus A; Raulet DH
    Curr Opin Immunol; 2016 Feb; 38():52-8. PubMed ID: 26686774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy meets targeted therapy: will this team end the war against cancer?
    Morales-Espinosa D; García-Román S; Teixidó C; Karachaliou N; Rosell R
    Transl Lung Cancer Res; 2015 Dec; 4(6):752-5. PubMed ID: 26798584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of immunotherapy.
    Suzuki S; Ishida T; Yoshikawa K; Ueda R
    Jpn J Clin Oncol; 2016 Mar; 46(3):191-203. PubMed ID: 26819277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propelling Immunotherapy Combinations Into the Clinic.
    Tchekmedyian N; Gray JE; Creelan BC; Chiappori AA; Beg AA; Soliman H; Perez BA; Antonia SJ
    Oncology (Williston Park); 2015 Dec; 29(12):990-1002. PubMed ID: 26680224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.
    Carvalho S; Levi-Schaffer F; Sela M; Yarden Y
    Br J Pharmacol; 2016 May; 173(9):1407-24. PubMed ID: 26833433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
    Yuan J; Hegde PS; Clynes R; Foukas PG; Harari A; Kleen TO; Kvistborg P; Maccalli C; Maecker HT; Page DB; Robins H; Song W; Stack EC; Wang E; Whiteside TL; Zhao Y; Zwierzina H; Butterfield LH; Fox BA
    J Immunother Cancer; 2016; 4():3. PubMed ID: 26788324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
    Finnigan JP; Rubinsteyn A; Hammerbacher J; Bhardwaj N
    Oncology (Williston Park); 2015 Dec; 29(12):970-2, 974-5. PubMed ID: 26676902
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer immune contexture and immunotherapy.
    Becht E; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
    Curr Opin Immunol; 2016 Apr; 39():7-13. PubMed ID: 26708937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of immunopharmacogenomics in cancer treatment: Patient selection and monitoring for immune checkpoint antibodies.
    Choudhury N; Nakamura Y
    Cancer Sci; 2016 Feb; 107(2):107-15. PubMed ID: 26678880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the indoleamine 2,3-dioxygenase pathway in cancer.
    Moon YW; Hajjar J; Hwu P; Naing A
    J Immunother Cancer; 2015; 3():51. PubMed ID: 26674411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T Cells and Cancer: How Metabolism Shapes Immunity.
    Molon B; Calì B; Viola A
    Front Immunol; 2016; 7():20. PubMed ID: 26870036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunoprevention.
    Finn OJ; Beatty PL
    Curr Opin Immunol; 2016 Apr; 39():52-8. PubMed ID: 26799207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Drugs and Combination Therapies for the Treatment of Metastatic Melanoma.
    Vennepureddy A; Thumallapally N; Motilal Nehru V; Atallah JP; Terjanian T
    J Clin Med Res; 2016 Feb; 8(2):63-75. PubMed ID: 26767073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.